BioSpherix, LLC. specializes in advanced cell and tissue culture technologies, focusing on creating Cytocentric® environments that prioritize the needs of cells for optimal care. Their product lineup includes precision gas controllers, incubator subchambers, and the innovative Xvivo System®, which features patented self-sanitizing technology. This modular and economical system serves as a superior alternative to traditional open systems, minimizing exposure to variable and non-physiologic conditions that can compromise cell integrity. BioSpherix's commitment to providing physiologic environments enhances cell viability, credibility, and reproducibility in research, while also improving economic efficiency by reducing operational costs and resource usage.

The company’s offerings are customizable and scalable, allowing researchers and manufacturers to tailor solutions to their specific needs. Products like the C-Chamber, OxyCycler, and ProCO₂ controllers enable precise control of environmental conditions, such as oxygen and carbon dioxide levels, which are critical for various experimental protocols. BioSpherix's technology is designed to ensure higher quality cells, leading to better data and results, while also facilitating reduced processing times and contamination risks. Their systems are compatible with a range of existing equipment, making them versatile tools for advancing research in cell therapy and tissue engineering.

United States

Our unique modular closure system is called the Xvivo System model X2. Many people dismiss it as simply another isolator. It does look like one and has glove access where necessary in the workflow. However, unlike isolators it has extensive plug-and-play modularity so it can enclose any production process. Less obvious but just as important, it can easily be reconfigured to quickly accommodate any changes or improvements to the process such as new equipment or automation, or as you need to scale

BioSpherix, LLC.

Company Details